Invasive fungal infection in children with persistent febrile neutropenia

Journal of the Formosan Medical Association

Volumn 104, Issue 3, 2005, Pages 174-179

  Lai, Hsin Pao ^a   Chen, Yee Chun ^b   Chang, Luan Yin ^b   Lu, Chun Yi ^b   Lee, Chin Yun ^b   Lin, Kai Hsin ^b   Huang, Li Min ^b  

^a God's Help Hospital   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Fever; Mycoses; Neutropenia; Risk factors; Treatment outcome

Indexed keywords

AMIKACIN; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CEFTAZIDIME; COTRIMOXAZOLE; GENTAMICIN; PIPERACILLIN; TIMENTIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEBRILE NEUTROPENIA; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INFECTION RISK; LIVER ABSCESS; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PARANASAL SINUSITIS; PNEUMONIA; PROGNOSIS; RETROSPECTIVE STUDY; SPLEEN ABSCESS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; CHI SQUARE DISTRIBUTION; FEVER; NEOPLASM; NEUTROPENIA; NONPARAMETRIC TEST; PRESCHOOL CHILD; RISK FACTOR; STATISTICAL MODEL;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; INFANT; LOGISTIC MODELS; MALE; MYCOSES; NEOPLASMS; NEUTROPENIA; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 19144362729     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Marr KA, Carter RA, Crippa F, et al: Epidemiology and outcome of mold infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:909-17.
2. Husain S, Alexander BD, Munoz P, et al: Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003;37:221-9.
3. Patterson TF, Kirkpatrick WR, White M, et al: Invasive aspergillosis: disease spectrum, treatment practices, and outcomes. Medicine (Baltimore) 2000;79:250-60.
4. Denning DW, Stevens DA: Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990;12:1147-200.
5. Kontoyiannis DP, Wessel VC, Bodey GP, et al: Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000;30:851-6.
6. Antoniadou A, Torres HA, Lewis RE, et al: Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore) 2003;82:309-21.
7. Chen CY, Chen YC, Tang JL, et al: Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment and prognosis. Ann Hematol 2003;82:1-9.
8. Thaler M, Pastakia B, Shawker TH, et al: Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 1988;108:88-100.
9. Denning DW, Kibbler CC, Barnes RA: British Society for Medical Mycology. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003;3:230-40.
10. Pizzo PA, Robichaud KJ, Gill FA, et al: Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982;72:101-11.
11. Hughes WT, Armstrong D, Bodey GP, et al: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51.
12. Walsh TJ, Finberg RW, Arndt C, et al: Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 1999;340:764-71.
13. Walsh TJ, Pappas P, Winston DJ, et al: Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002;346:225-34.
14. Pollack MM, Ruttimann UE, Getson PR: Pediatric Risk of Mortality (PRISM) score. Crit Care Med 1988;16:1110-6.
15. Bodey GP, Buckley M, Sathe YS, et al: Quantitative relationship between circulating leukocytes and infections in patients with acute leukemia. Ann Intern Med 1966;64:328-39.
16. Ascioglu S, Rex JH, de Pauw B, et al: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
17. Herbrecht R, Damonte JC, Bergerat JP, et al: Piperacillin and netilmicin combination therapy for febrile episodes in neutropenic patients. Infection 1990;18:310-3.
18. Yu LC, Shaneyfelt T, Warrier R, et al: The efficacy of ticarcillin-clavulanate and gentamicin as empiric treatment for febrile neutropenic pediatric patients with cancer. Pediatr Hematol Oncol 1994;11:181-7.
19. Chiu HH, Huang LM, Lee PI, et al: Bacteremia and fungemia in hematological and oncological children with neutropenic fever: two-year study in a medical center. J Microbiol Immunol Infect 1998;31:101-6.
20. Guiot HFL, Fibbe WE, Wout JW: Risk factors of fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994;18:525-32.
21. Aisner J, Schimpff SC, Wiernik H: Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 1977;86:539-43.